Cargando…
Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options
Epithelial ovarian cancer (EOC) is a significant cause of cancer-related mortality in women. Despite advances in diagnosis and treatment, EOC remains a challenging disease to manage, and the 5-year survival rate is still poor. The role of hormone receptors (HRs) in EOC carcinogenesis and prognosis h...
Autores principales: | Borella, Fulvio, Fucina, Stefano, Mangherini, Luca, Cosma, Stefano, Carosso, Andrea Roberto, Cusato, Jessica, Cassoni, Paola, Bertero, Luca, Katsaros, Dionyssios, Benedetto, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452581/ https://www.ncbi.nlm.nih.gov/pubmed/37626654 http://dx.doi.org/10.3390/biomedicines11082157 |
Ejemplares similares
-
Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis
por: Borella, Fulvio, et al.
Publicado: (2020) -
Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives
por: Borella, Fulvio, et al.
Publicado: (2020) -
Update on Prognostic and Predictive Markers in Mucinous Ovarian Cancer
por: Borella, Fulvio, et al.
Publicado: (2023) -
Placenta histopathology in SARS-CoV-2 infection: analysis of a consecutive series and comparison with control cohorts
por: Bertero, Luca, et al.
Publicado: (2021) -
Obstetric and neonatal outcomes after SARS‐CoV‐2 infection in the first trimester of pregnancy: A prospective comparative study
por: Cosma, Stefano, et al.
Publicado: (2021)